|
Name |
calicoferol D
|
Molecular Formula | C28H42O2 | |
IUPAC Name* |
(1R,3aS,7aR)-1-[(E,2S)-3,6-dimethylhept-3-en-2-yl]-4-[2-(5-hydroxy-2-methylphenyl)ethyl]-7a-methyl-2,3,3a,4,6,7-hexahydro-1H-inden-5-one
|
|
SMILES |
CC1=C(C=C(C=C1)O)CCC2[C@@H]3CC[C@@H]([C@]3(CCC2=O)C)[C@H](C)/C(=C/CC(C)C)/C
|
|
InChI |
InChI=1S/C28H42O2/c1-18(2)7-8-19(3)21(5)25-13-14-26-24(27(30)15-16-28(25,26)6)12-10-22-17-23(29)11-9-20(22)4/h8-9,11,17-18,21,24-26,29H,7,10,12-16H2,1-6H3/b19-8+/t21-,24?,25-,26+,28-/m1/s1
|
|
InChIKey |
VCPSCMZUIRKCJL-HOCQEXNISA-N
|
|
Synonyms |
calicoferol D; (22E)-(8S)-3-hydroxy-22-methyl-9,10-seco-1,3,5(10),22-cholestatetraen-9-one; CHEBI:180195; LMST03020313; (1R,3aS,7aR)-1-[(E,2S)-3,6-dimethylhept-3-en-2-yl]-4-[2-(5-hydroxy-2-methylphenyl)ethyl]-7a-methyl-2,3,3a,4,6,7-hexahydro-1H-inden-5-one
|
|
CAS | NA | |
PubChem CID | 5283765 | |
ChEMBL ID | CHEMBL456935 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 410.6 | ALogp: | 7.9 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 37.3 | Aromatic Rings: | 3 |
Heavy Atoms: | 30 | QED Weighted: | 0.479 |
Caco-2 Permeability: | -4.814 | MDCK Permeability: | 0.00001320 |
Pgp-inhibitor: | 0.614 | Pgp-substrate: | 0.013 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.959 |
30% Bioavailability (F30%): | 0.961 |
Blood-Brain-Barrier Penetration (BBB): | 0.736 | Plasma Protein Binding (PPB): | 98.81% |
Volume Distribution (VD): | 2.172 | Fu: | 1.41% |
CYP1A2-inhibitor: | 0.233 | CYP1A2-substrate: | 0.703 |
CYP2C19-inhibitor: | 0.57 | CYP2C19-substrate: | 0.883 |
CYP2C9-inhibitor: | 0.607 | CYP2C9-substrate: | 0.954 |
CYP2D6-inhibitor: | 0.73 | CYP2D6-substrate: | 0.897 |
CYP3A4-inhibitor: | 0.923 | CYP3A4-substrate: | 0.486 |
Clearance (CL): | 9.202 | Half-life (T1/2): | 0.274 |
hERG Blockers: | 0.099 | Human Hepatotoxicity (H-HT): | 0.272 |
Drug-inuced Liver Injury (DILI): | 0.363 | AMES Toxicity: | 0.009 |
Rat Oral Acute Toxicity: | 0.193 | Maximum Recommended Daily Dose: | 0.931 |
Skin Sensitization: | 0.847 | Carcinogencity: | 0.038 |
Eye Corrosion: | 0.142 | Eye Irritation: | 0.309 |
Respiratory Toxicity: | 0.922 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003337 | 0.305 | D07VBA | 0.311 | ||||
ENC001942 | 0.303 | D00ZFP | 0.299 | ||||
ENC002882 | 0.299 | D08QMX | 0.287 | ||||
ENC005239 | 0.299 | D0W6DG | 0.284 | ||||
ENC001764 | 0.299 | D0U0XD | 0.277 | ||||
ENC001475 | 0.292 | D03DXN | 0.274 | ||||
ENC002191 | 0.291 | D0Z1FX | 0.270 | ||||
ENC006033 | 0.291 | D0K5WS | 0.270 | ||||
ENC003458 | 0.289 | D0Y7LD | 0.269 | ||||
ENC003797 | 0.287 | D0T7ZQ | 0.267 |